[ { "@graph" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#pubinfo" } ] } ], "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#Head" }, { "@graph" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_9164", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#association", "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/DOID_9164" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "https://identifiers.org/drugbank:DB00630" } ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "\"FOSAMAX is contraindicated in patients with the following conditions: Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [see Warnings and Precautions (5.1) Inability to stand or sit upright for at least 30 minutes [see Dosage and Administration (2.6) Warnings and Precautions (5.1) Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. Hypocalcemia [see Warnings and Precautions (5.2) Hypersensitivity to any component of this product. Hypersensitivity reactions including urticaria and angioedema have been reported [see Adverse Reactions (6.2) Abnormalities of the esophagus which delay emptying such as stricture or achalasia ( 4 5.1 Inability to stand/sit upright for at least 30 minutes ( 2.6 4 5.1 Do not administer FOSAMAX oral solution to patients at increased risk of aspiration. ( 4 Hypocalcemia ( 4 5.2 Hypersensitivity to any component of this product ( 4 6.2\"" } ], "https://w3id.org/biolink/vocab/provided_by" : [ { "@id" : "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation" : [ { "@id" : "https://schema.org/MedicalContraindication" } ] }, { "@id" : "https://identifiers.org/drugbank:DB00630", "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Drug" } ] } ], "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#assertion", "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ] } ], "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg", "http://purl.org/dc/terms/created" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2021-08-23T13:03:35.050+02:00" } ], "http://purl.org/dc/terms/creator" : [ { "@id" : "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ { "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ { "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ { "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY" } ] }, { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "IeCuS7sJs8ZrSUHIlcK5Bs6pGrLjszoFbikvxCH2+AEl3OdS96G1p96FX+BTVm3yIGY/xM+GfGA0PwVUKi25fvhXOfE5z9PrcedEfefiFCjKp+/YTZ+7dVIEcUB0ZQEp3r5GvWmQTm9kA5jjFziqYXmmlGQYEdZyl5yRDe6izkY=" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg" } ] } ], "@id" : "http://purl.org/np/RAhZAqxG-GpkcDR0aMDd2ymItam2JxwJETPbOjZFlPvvg#pubinfo" } ]